[1]
2024. Clinical impact of tocilizumab in treatment of severe COVID-19 patients: Retrospective cohort study. Actualizaciones en Sida e Infectología. 32, 115 (Jun. 2024). DOI:https://doi.org/10.52226/revista.v32i115.284.